This synergy is probably a result of the de novo induction of ERV dsRNAs, primarily derived from ERVK and ERV1 class TEs, by 5-Aza-CdR, thus creating a new or additional ADAR1 dependency in those cancer cells. The gene discussed is ADAR; the disease is cancer.